Last 12 months
Inside the activity.
0 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 05, 2022 Filed Apr 8, 2022 01:47 UTC |
Johnson Kevin JChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 6,575 | $0.00 Strike: $55.96 | $0.00 |
DisclosureSEC source: 0001209191-22-023784 · doc4.xml · derivative · entry 8 Johnson Kevin J · CIK 0001910487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,575 Underlying: Common stock, par value $0.001 · 6,575 shares Expires 2028-02-21 F8 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F10 · derivative.exercise_date: 2,732 shares of the option have already vested. The remaining shares of the option will fully vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:47 UTC |
Johnson Kevin JChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,300 | $0.00 Strike: $46.94 | $0.00 |
DisclosureSEC source: 0001209191-22-023784 · doc4.xml · derivative · entry 7 Johnson Kevin J · CIK 0001910487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,300 Underlying: Common stock, par value $0.001 · 7,300 shares Expires 2027-02-23 F8 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F9 · derivative.exercise_date: 6,066 shares of the option have already vested. The remaining shares of the option will fully vest and become exercisable in a single installment on February 24, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:47 UTC |
Johnson Kevin JChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 9,139 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001209191-22-023784 · doc4.xml · derivative · entry 6 Johnson Kevin J · CIK 0001910487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,139 Underlying: Common stock, par value $0.001 · 9,139 shares Expires 2026-02-24 F8 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:47 UTC |
Johnson Kevin JChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 5,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023784 · doc4.xml · derivative · entry 5 Johnson Kevin J · CIK 0001910487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,133 Underlying: Common stock, par value $0.001 · 5,133 shares Expires 2025-02-17 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F7 · derivative.exercise_date: These restricted stock units vest in three equal annual installments beginning on February 17, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:47 UTC |
Johnson Kevin JChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 1,779 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023784 · doc4.xml · derivative · entry 4 Johnson Kevin J · CIK 0001910487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,779 Underlying: Common stock, par value $0.001 · 1,779 shares Expires 2024-02-22 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F6 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:47 UTC |
Johnson Kevin JChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 1,823 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023784 · doc4.xml · derivative · entry 3 Johnson Kevin J · CIK 0001910487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,823 Underlying: Common stock, par value $0.001 · 1,823 shares Expires 2023-07-25 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F5 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on July 25, 2022 and July 25, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:47 UTC |
Johnson Kevin JChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 798 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023784 · doc4.xml · derivative · entry 2 Johnson Kevin J · CIK 0001910487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 798 Underlying: Common stock, par value $0.001 · 798 shares Expires 2023-02-24 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F4 · derivative.exercise_date: These restricted stock units vest and become exercisable in a single installment on February 24, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:47 UTC |
Johnson Kevin JChief Financial Officer
|
GrantCommon stock, par value $0.001 | 3,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023784 · doc4.xml · nonDerivative · entry 1 Johnson Kevin J · CIK 0001910487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,092 F1 · balance_after: Shares acquired in the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB Corporation ("ESAB"). Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:45 UTC |
Hix Christopher MDirector
|
GrantRestricted Stock Units · Derivative | 9,649 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023782 · doc4.xml · derivative · entry 4 Hix Christopher M · CIK 0001357529 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,649 Underlying: Common stock, par value $0.001 · 9,649 shares Expires 2025-02-17 F1 · derivative.exercise_price: Each restricted stock unit or performance restricted stock unit represents a contingent right to receive one share of ESAB Corporation ("ESAB") common stock. F2 · kind: In connection with the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. For Mr. Hix, who, following the Spin-Off, will continue to serve as Executive Vice President, Finance and Chief Financial Officer of Enovis (fka Colfax) and will serve as a non-employee director of ESAB, 50% of his RSU awards have been converted into ESAB equity awards. F6 · derivative.exercise_date: These restricted stock units vest in three equal annual installments beginning on February 17, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:45 UTC |
Hix Christopher MDirector
|
GrantRestricted Stock Units · Derivative | 3,346 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023782 · doc4.xml · derivative · entry 3 Hix Christopher M · CIK 0001357529 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,346 Underlying: Common stock, par value $0.001 · 3,346 shares Expires 2024-02-22 F1 · derivative.exercise_price: Each restricted stock unit or performance restricted stock unit represents a contingent right to receive one share of ESAB Corporation ("ESAB") common stock. F2 · kind: In connection with the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. For Mr. Hix, who, following the Spin-Off, will continue to serve as Executive Vice President, Finance and Chief Financial Officer of Enovis (fka Colfax) and will serve as a non-employee director of ESAB, 50% of his RSU awards have been converted into ESAB equity awards. F5 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:45 UTC |
Hix Christopher MDirector
|
GrantRestricted Stock Units · Derivative | 1,815 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023782 · doc4.xml · derivative · entry 2 Hix Christopher M · CIK 0001357529 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,815 Underlying: Common stock, par value $0.001 · 1,815 shares Expires 2023-02-24 F1 · derivative.exercise_price: Each restricted stock unit or performance restricted stock unit represents a contingent right to receive one share of ESAB Corporation ("ESAB") common stock. F2 · kind: In connection with the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. For Mr. Hix, who, following the Spin-Off, will continue to serve as Executive Vice President, Finance and Chief Financial Officer of Enovis (fka Colfax) and will serve as a non-employee director of ESAB, 50% of his RSU awards have been converted into ESAB equity awards. F4 · derivative.exercise_date: These restricted stock units vest and become exercisable in a single installment on February 24, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:45 UTC |
Hix Christopher MDirector
|
GrantRestricted Stock Units · Derivative | 3,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023782 · doc4.xml · derivative · entry 1 Hix Christopher M · CIK 0001357529 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,930 Underlying: Common stock, par value $0.001 · 3,930 shares Expires 2022-12-13 F1 · derivative.exercise_price: Each restricted stock unit or performance restricted stock unit represents a contingent right to receive one share of ESAB Corporation ("ESAB") common stock. F2 · kind: In connection with the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. For Mr. Hix, who, following the Spin-Off, will continue to serve as Executive Vice President, Finance and Chief Financial Officer of Enovis (fka Colfax) and will serve as a non-employee director of ESAB, 50% of his RSU awards have been converted into ESAB equity awards. F3 · derivative.exercise_date: These restricted stock units vest and become exercisable in a single installment on December 13, 2022. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:43 UTC |
Campion MicheleChief Human Resources Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 4,672 | $0.00 Strike: $55.96 | $0.00 |
DisclosureSEC source: 0001209191-22-023779 · doc4.xml · derivative · entry 7 Campion Michele · CIK 0001911320 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,672 Underlying: Common stock, par value $0.001 · 4,672 shares Expires 2028-02-21 F8 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F10 · derivative.exercise_date: 1,942 shares of the option have already vested. The remaining shares of the option will fully vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:43 UTC |
Campion MicheleChief Human Resources Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,864 | $0.00 Strike: $41.79 | $0.00 |
DisclosureSEC source: 0001209191-22-023779 · doc4.xml · derivative · entry 6 Campion Michele · CIK 0001911320 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,864 Underlying: Common stock, par value $0.001 · 5,864 shares Expires 2027-09-13 F8 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F9 · derivative.exercise_date: 2,437 shares of the option have already vested. The remaining shares of the option will fully vest and become exercisable in two equal installments on September 14, 2022 and September 14, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:43 UTC |
Campion MicheleChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 3,756 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023779 · doc4.xml · derivative · entry 5 Campion Michele · CIK 0001911320 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,756 Underlying: Common stock, par value $0.001 · 3,756 shares Expires 2025-02-17 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F7 · derivative.exercise_date: These restricted stock units vest in three equal annual installments beginning on February 17, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:43 UTC |
Campion MicheleChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 1,264 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023779 · doc4.xml · derivative · entry 4 Campion Michele · CIK 0001911320 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,264 Underlying: Common stock, par value $0.001 · 1,264 shares Expires 2024-02-22 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F6 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:43 UTC |
Campion MicheleChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 1,506 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023779 · doc4.xml · derivative · entry 3 Campion Michele · CIK 0001911320 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,506 Underlying: Common stock, par value $0.001 · 1,506 shares Expires 2023-09-14 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F5 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on September 14, 2022 and September 14, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:43 UTC |
Campion MicheleChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 2,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023779 · doc4.xml · derivative · entry 2 Campion Michele · CIK 0001911320 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,311 Underlying: Common stock, par value $0.001 · 2,311 shares Expires 2023-09-14 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F4 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on September 14, 2022 and September 14, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:43 UTC |
Campion MicheleChief Human Resources Officer
|
GrantCommon stock, par value $0.001 | 688 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023779 · doc4.xml · nonDerivative · entry 1 Campion Michele · CIK 0001911320 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 688 F1 · balance_after: Shares acquired in the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB Corporation ("ESAB"). Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC |
Coble LarrySVP, EBX & Supply Chain
|
GrantEmployee Stock Option (right to buy) · Derivative | 6,402 | $0.00 Strike: $41.63 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · derivative · entry 11 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,402 Underlying: Common stock, par value $0.001 · 6,402 shares Expires 2025-03-07 F9 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC |
Coble LarrySVP, EBX & Supply Chain
|
GrantEmployee Stock Option (right to buy) · Derivative | 22,370 | $0.00 Strike: $46.04 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · derivative · entry 10 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,370 Underlying: Common stock, par value $0.001 · 22,370 shares Expires 2024-11-06 F9 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC |
Coble LarrySVP, EBX & Supply Chain
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,415 | $0.00 Strike: $55.96 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · derivative · entry 9 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,415 Underlying: Common stock, par value $0.001 · 7,415 shares Expires 2028-02-21 F9 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F11 · derivative.exercise_date: 3,081 shares of the option have already vested. The remaining shares of the option will fully vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC |
Coble LarrySVP, EBX & Supply Chain
|
GrantEmployee Stock Option (right to buy) · Derivative | 6,138 | $0.00 Strike: $46.94 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · derivative · entry 8 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,138 Underlying: Common stock, par value $0.001 · 6,138 shares Expires 2027-02-23 F9 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F10 · derivative.exercise_date: 5,101 shares of the option have already vested. The remaining shares of the option will fully vest and become exercisable in a single installment on February 24, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC |
Coble LarrySVP, EBX & Supply Chain
|
GrantEmployee Stock Option (right to buy) · Derivative | 11,424 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · derivative · entry 7 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,424 Underlying: Common stock, par value $0.001 · 11,424 shares Expires 2026-02-24 F9 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC |
Coble LarrySVP, EBX & Supply Chain
|
GrantRestricted Stock Units · Derivative | 5,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · derivative · entry 6 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,210 Underlying: Common stock, par value $0.001 · 5,210 shares Expires 2025-02-17 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F8 · derivative.exercise_date: These restricted stock units vest in three equal annual installments beginning on February 17, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC |
Coble LarrySVP, EBX & Supply Chain
|
GrantRestricted Stock Units · Derivative | 2,007 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · derivative · entry 5 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,007 Underlying: Common stock, par value $0.001 · 2,007 shares Expires 2024-02-22 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F7 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC |
Coble LarrySVP, EBX & Supply Chain
|
GrantRestricted Stock Units · Derivative | 911 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · derivative · entry 4 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 911 Underlying: Common stock, par value $0.001 · 911 shares Expires 2023-07-25 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F6 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on July 25, 2022 and July 25, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC |
Coble LarrySVP, EBX & Supply Chain
|
GrantRestricted Stock Units · Derivative | 670 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · derivative · entry 3 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 670 Underlying: Common stock, par value $0.001 · 670 shares Expires 2023-02-24 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F5 · derivative.exercise_date: These restricted stock units vest and become exercisable in a single installment on February 24, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC |
Coble LarrySVP, EBX & Supply Chain
|
GrantRestricted Stock Units · Derivative | 245 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · derivative · entry 2 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245 Underlying: Common stock, par value $0.001 · 245 shares Expires 2022-08-07 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F4 · derivative.exercise_date: These restricted stock units vest and become exercisable in a single installment on August 7, 2022. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC |
Coble LarrySVP, EBX & Supply Chain
|
GrantCommon stock, par value $0.001 | 4,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · nonDerivative · entry 1 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,438 F1 · balance_after: Shares acquired in the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB Corporation ("ESAB"). Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:45 UTC |
Enovis CORP10% owner
|
OtherCommon stock, par value $.001 | 54,030,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023781 · doc4.xml · nonDerivative · entry 1 Enovis CORP · CIK 0001420800 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,003,431 F1 · kind: In connection with the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB Corporation ("ESAB"), Enovis Corporation ("Enovis") (fka Colfax) distributed an aggregate of 54,030,880 shares of ESAB common stock. F2 · shares: In connection with the Spin-Off, the 1,000 shares of common stock of ESAB held by Enovis were reclassified into 60,034,311 shares of common stock of ESAB. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:42 UTC |
Biebuyck OlivierPresident, EMEA
|
GrantRestricted Stock Units · Derivative | 5,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023778 · doc4.xml · derivative · entry 10 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,808 Underlying: Common stock, par value $0.001 · 5,808 shares Expires 2025-02-17 F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F6 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F11 · derivative.exercise_date: These restricted stock units vest in three equal annual installments beginning on February 17, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:42 UTC |
Biebuyck OlivierPresident, EMEA
|
GrantRestricted Stock Units · Derivative | 2,014 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023778 · doc4.xml · derivative · entry 9 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,014 Underlying: Common stock, par value $0.001 · 2,014 shares Expires 2024-02-22 F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F6 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F10 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:42 UTC |
Biebuyck OlivierPresident, EMEA
|
GrantRestricted Stock Units · Derivative | 1,823 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023778 · doc4.xml · derivative · entry 8 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,823 Underlying: Common stock, par value $0.001 · 1,823 shares Expires 2023-07-25 F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F6 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F9 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on July 25, 2022 and July 25, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:42 UTC |
Biebuyck OlivierPresident, EMEA
|
GrantRestricted Stock Units · Derivative | 965 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023778 · doc4.xml · derivative · entry 7 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 965 Underlying: Common stock, par value $0.001 · 965 shares Expires 2023-02-24 F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F6 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F8 · derivative.exercise_date: These restricted stock units vest and become exercisable in a single installment on February 24, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:42 UTC |
Biebuyck OlivierPresident, EMEA
|
GrantRestricted Stock Units · Derivative | 491 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023778 · doc4.xml · derivative · entry 6 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 491 Underlying: Common stock, par value $0.001 · 491 shares Expires 2022-08-07 F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F6 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F7 · derivative.exercise_date: These restricted stock units vest and become exercisable in a single installment on August 7, 2022. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:42 UTC |
Biebuyck OlivierPresident, EMEA
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,440 | $0.00 Strike: $55.96 | $0.00 |
DisclosureSEC source: 0001209191-22-023778 · doc4.xml · derivative · entry 5 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,440 Underlying: Common stock, par value $0.001 · 7,440 shares Expires 2028-02-21 F2 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F4 · derivative.exercise_date: 3,092 shares of the option have already vested. The remaining shares of the option will fully vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:42 UTC |
Biebuyck OlivierPresident, EMEA
|
GrantEmployee Stock Option (right to buy) · Derivative | 8,826 | $0.00 Strike: $46.94 | $0.00 |
DisclosureSEC source: 0001209191-22-023778 · doc4.xml · derivative · entry 4 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,826 Underlying: Common stock, par value $0.001 · 8,826 shares Expires 2027-02-23 F2 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F3 · derivative.exercise_date: 7,334 shares of the option have already vested. The shares of the option will fully vest and become exercisable in a single installment on February 24, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:42 UTC |
Biebuyck OlivierPresident, EMEA
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,809 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001209191-22-023778 · doc4.xml · derivative · entry 3 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,809 Underlying: Common stock, par value $0.001 · 3,809 shares Expires 2026-02-24 F2 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:42 UTC |
Biebuyck OlivierPresident, EMEA
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,182 | $0.00 Strike: $51.68 | $0.00 |
DisclosureSEC source: 0001209191-22-023778 · doc4.xml · derivative · entry 2 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,182 Underlying: Common stock, par value $0.001 · 7,182 shares Expires 2024-05-31 F2 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:42 UTC |
Biebuyck OlivierPresident, EMEA
|
GrantCommon stock, par value $0.001 | 2,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023778 · doc4.xml · nonDerivative · entry 1 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,731 F1 · balance_after: Shares acquired in the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB Corporation ("ESAB"). Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:41 UTC |
ALLENDER PATRICK WDirector
|
GrantStock Option (right to buy) · Derivative | 4,733 | $0.00 Strike: $33.33 | $0.00 |
DisclosureSEC source: 0001209191-22-023777 · doc4.xml · derivative · entry 11 ALLENDER PATRICK W · CIK 0001205268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,733 Underlying: Common stock, par value $0.001 · 4,733 shares Expires 2027-05-20 F3 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:41 UTC |
ALLENDER PATRICK WDirector
|
GrantStock Option (right to buy) · Derivative | 5,567 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001209191-22-023777 · doc4.xml · derivative · entry 10 ALLENDER PATRICK W · CIK 0001205268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,567 Underlying: Common stock, par value $0.001 · 5,567 shares Expires 2026-05-13 F3 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:41 UTC |
ALLENDER PATRICK WDirector
|
GrantStock Option (right to buy) · Derivative | 4,254 | $0.00 Strike: $40.55 | $0.00 |
DisclosureSEC source: 0001209191-22-023777 · doc4.xml · derivative · entry 9 ALLENDER PATRICK W · CIK 0001205268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,254 Underlying: Common stock, par value $0.001 · 4,254 shares Expires 2025-05-16 F3 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:41 UTC |
ALLENDER PATRICK WDirector
|
GrantStock Option (right to buy) · Derivative | 3,400 | $0.00 Strike: $49.42 | $0.00 |
DisclosureSEC source: 0001209191-22-023777 · doc4.xml · derivative · entry 8 ALLENDER PATRICK W · CIK 0001205268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,400 Underlying: Common stock, par value $0.001 · 3,400 shares Expires 2024-05-17 F3 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:41 UTC |
ALLENDER PATRICK WDirector
|
GrantStock Option (right to buy) · Derivative | 3,810 | $0.00 Strike: $31.10 | $0.00 |
DisclosureSEC source: 0001209191-22-023777 · doc4.xml · derivative · entry 7 ALLENDER PATRICK W · CIK 0001205268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,810 Underlying: Common stock, par value $0.001 · 3,810 shares Expires 2023-05-12 F3 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:41 UTC |
ALLENDER PATRICK WDirector
|
GrantStock Option (right to buy) · Derivative | 2,318 | $0.00 Strike: $63.37 | $0.00 |
DisclosureSEC source: 0001209191-22-023777 · doc4.xml · derivative · entry 6 ALLENDER PATRICK W · CIK 0001205268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,318 Underlying: Common stock, par value $0.001 · 2,318 shares Expires 2022-05-12 F3 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:41 UTC |
ALLENDER PATRICK WDirector
|
GrantCommon stock, par value $0.001 | 30,043 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023777 · doc4.xml · nonDerivative · entry 5 ALLENDER PATRICK W · CIK 0001205268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By JWA Irrevocable Trust #2 Disclosed balance after: 30,043 F1 · balance_after: Shares acquired in the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB Corporation ("ESAB"). F2 · balance_after: The reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for the purposes of Section 16 or for any other purpose. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:41 UTC |
ALLENDER PATRICK WDirector
|
GrantCommon stock, par value $0.001 | 19,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023777 · doc4.xml · nonDerivative · entry 4 ALLENDER PATRICK W · CIK 0001205268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By JWA GRAT #5 Disclosed balance after: 19,326 F1 · balance_after: Shares acquired in the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB Corporation ("ESAB"). F2 · balance_after: The reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for the purposes of Section 16 or for any other purpose. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:41 UTC |
ALLENDER PATRICK WDirector
|
GrantCommon stock, par value $0.001 | 9,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023777 · doc4.xml · nonDerivative · entry 3 ALLENDER PATRICK W · CIK 0001205268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By JWA GRAT #4 Disclosed balance after: 9,168 F1 · balance_after: Shares acquired in the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB Corporation ("ESAB"). F2 · balance_after: The reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for the purposes of Section 16 or for any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.